Page 452 - Basic _ Clinical Pharmacology ( PDFDrive )

438 SECTION V Drugs That Act in the Central Nervous System

PREP AR A TIONS A V AIL ABLE

GENERIC NAME AVAILABLE AS GENERIC NAME AVAILABLE AS
Carbamazepine forms Methsuximide Celontin
Carbamazepine Generic, Tegretol Oxcarbazepine Generic, Trileptal, Oxtellar XR
Carbamazepine injection Carnexiv Pentobarbital sodium Generic, Nembutal Sodium
Clobazam Onfi Perampanel Fycompa
Clonazepam Generic, Klonopin Phenobarbital Generic, Luminal Sodium,
Clorazepate dipotassium Generic, Tranxene others
Diazepam forms Phenytoin Phenytoin, Dilantin, others
Diazepam Generic, Valium, others Pregabalin Lyrica
Diazepam rectal gel Diastat Acudial Primidone Generic, Mysoline
Eslicarbazepine acetate Aptiom, Stedesa Retigabine (ezogabine) Potiga, Trobalt
Ethosuximide Generic, Zarontin Rufinamide Banzel
Ethotoin Peganone Stiripentol Diacomit
Felbamate Generic, Felbatol Tiagabine Generic, Gabitril
Fosphenytoin Generic, Cerebyx Topiramate forms
Gabapentin Generic, Neurontin, Gralise Topiramate Generic, Topamax
Gabapentin enacarbil Horizant Topiramate extended release Trokendi XR, Qudexy XR
Lacosamide forms Trimethadione Tridione
Lacosamide Vimpat Valproate/valproic acid forms
Lacosamide injection Vimpat injection Valproic acid Generic, Depakene
Lamotrigine forms Divalproex sodium delayed Generic, Depakote
Lamotrigine Generic, Lamictal release
Lamotrigine extended release Generic, Lamictal XR Divalproex sodium extended Depakote ER
Levetiracetam Generic, Keppra, Spritam release
Lorazepam Generic, Ativan Valproate sodium injection Generic, Depacon
Mephenytoin Mesantoin (discontinued in Vigabatrin Sabril
United States) Zonisamide Generic, Zonegran

REFERENCES Porter RJ et al: AED mechanisms and principles of drug treatment. In: Stefan H,
Ettinger AB, Argoff CE: Use of antiepileptic drugs for non-epileptic conditions: Theodore W (editors): Handbook of Clinical Neurology, 3rd series, Epilepsies
Part 2: Treatment. Elsevier, 2012.
Psychiatric disorders and chronic pain. Neurotherapeutics 2007;4:75. Porter RJ et al: Clinical development of drugs for epilepsy: A review of approaches
French JA et al: Development of new treatment approaches for epilepsy: Unmet in the United States and Europe. Epilepsy Res 2010;89:163.
needs and opportunities. Epilepsia 2013;54(Suppl 4):3. Rogawski MA et al: Current understanding of the mechanism of action of the
Glauser TA et al: Ethosuximide, valproic acid, and lamotrigine in childhood antiepileptic drug lacosamide. Epilepsy Res 2015;110:189.
absence epilepsy. N Engl J Med 2010;362:790. Rogawski MA, Hanada T: Preclinical pharmacology of perampanel, a selective
Glauser TA et al: Evidence-based guideline: Treatment of convulsive status epi- non-competitive AMPA receptor antagonist. Acta Neurol Scand 2013;127
lepticus in children and adults: Report of the Guideline Committee of the (Suppl 197):19.
American Epilepsy Society. Epilepsy Curr 2016;16:48. Rogawski MA, Löscher W, Rho JM: Mechanisms of action of antisei-
Grover EH, Nazzal Y, Hirsch LJ: Treatment of convulsive status epilepticus. Curr zure drugs and the ketogenic diet. Cold Spring Harb Perspect Med
Treat Options Neurol 2016;18:11. 2016;6:a022780.
Haut SR: Seizure clusters: Characteristics and treatment. Curr Opin Neurol Steinhof BJ et al: Efficacy and safety of adjunctive perampanel for the treatment
2015;28:143. of refractory partial seizures: A pooled analysis of three phase III studies.
Kaminski RM et al: SV2A is a broad-spectrum anticonvulsant target: Functional Epilepsia 2013;54:1481.
correlation between protein binding and seizure protection in models of Vélez-Ruiz NJ, Pennell PB: Issues for women with epilepsy. Neurol Clin
both partial and generalized epilepsy. Neuropharmacology 2008;54:715. 2016;34:411.
Löscher W et al: Synaptic vesicle glycoprotein 2A ligands in the treatment of Wilcox KS et al: Issues related to development of new anti-seizure treatments.
epilepsy and beyond. CNS Drugs 2016;30:1055. Epilepsia 2013;54(Suppl 4):24.
Meldrum BS, Rogawski MA: Molecular targets for antiepileptic drug develop- Xie X et al: Electrophysiological and pharmacological properties of the human
ment. Neurotherapeutics 2007;4:18. brain type IIA Na channel expressed in a stable mammalian cell line.
+
Patsalos P: Antiepileptic Drug Interactions. A Clinical Guide. Springer International Pflugers Arch 2001;441:425.
Publishing, 2016. Xie X, Hagan RM: Cellular and molecular actions of lamotrigine: Possible mecha-
Patsalos PN: Drug interactions with the newer antiepileptic drugs (AEDs)—Part nisms of efficacy in bipolar disorder. Neuropsychobiology 1998;38:119.
1: Pharmacokinetic and pharmacodynamic interactions between AEDs. Clin
Pharmacokinet 2013;52:927.